Copyright
©The Author(s) 2024.
World J Clin Cases. Mar 26, 2024; 12(9): 1660-1668
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1660
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1660
Testing date | WBC as × 109/L | ALC as × 109/L | ANC as × 109/L | Hb in g/L | PLT as × 109/L | CRP in mg/L | PCT in ng/mL | Fib in g/L | TG in mmol/L | SF in mg/L | T in C | HR, times/min | RR, times/min | BP in mmHg | SpO2, % |
September 25, 2022 | 2.33 | 0.57 | 1.63 | 96 | 25 | 10.88 | 2.32 | 2.23 | 1.03 | > 1500 | 39.4 | 128 | 20 | 78/40 | > 95% |
September 26, 2022 | 2.74 | 0.83 | 1.8 | 109 | 36 | 11.52 | 2.8 | 1.93 | 1.39 | > 1500 | 35.6 | 16 | 30 | 91/70 | > 95% |
September 27, 2022 | 2.75 | 0.76 | 1.91 | 98 | 26 | 6.2 | 2.6 | NT | NT | NT | 35.5 | 78 | 20 | 103/67 | > 95% |
September 28, 2022 | 2.14 | 0.82 | 1.2 | 87 | 76 | 2.69 | NT | NT | NT | 1835.0 | 35.8 | 74 | 18 | 105/73 | > 95% |
September 29, 2022 | 2.51 | 1.08 | 1.23 | 89 | 70 | 1.01 | NT | 1.26 | NT | NT | 36.0 | 77 | 19 | 100/75 | > 95% |
September 30, 2022 | 2.81 | 0.97 | 1.71 | 92 | 58 | 0.48 | NT | 1.12 | 1.7 | NT | 36.0 | 102 | 18 | 83/54 | > 95% |
October 2, 2022 | 4.82 | 3.03 | 1.58 | 87 | 37 | 0.64 | NT | 1.59 | NT | 725.2 | 37.3 | 86 | 20 | 86/60 | > 95% |
October 3, 2022 | 3.93 | 2.23 | 1.63 | 81 | 38 | 0.38 | 0.291 | NT | NT | NT | 37.1 | 72 | 22 | 72/44 | > 95% |
October 4, 2022 | 6.31 | 4.73 | 1.35 | 84 | 29 | 0.5 | NT | NT | NT | NT | 38.4 | 123 | 23 | 90/58 | > 95% |
October 5, 2022 | 4.11 | 2.72 | 1.19 | 77 | 31 | 0.87 | NT | NT | NT | NT | 37.9 | 112 | 22 | 82/57 | > 95% |
October 6, 2022 | 4.04 | 2.94 | 0.94 | 74 | 50 | 1.1 | 0.118 | NT | NT | NT | 38.6 | 154 | 28 | 87/56 | > 95% |
October 7, 2022 | 3.67 | 2.78 | 0.68 | 77 | 50 | 1.79 | NT | NT | NT | NT | 37.8 | 120 | 16 | 97/69 | > 95% |
October 8, 2022 | 3.73 | 2.99 | 0.55 | 75 | 50 | 1.37 | NT | 3.44 | NT | 384.5 | 37.6 | 136 | 22 | 75/51 | > 95% |
October 9, 2022 | 3.53 | 2.36 | 0.92 | 105 | 50 | 0.92 | NT | NT | NT | NT | 37.6 | 105 | 23 | 108/76 | > 95% |
October 10, 2022 | 3.98 | 3.05 | 0.69 | 93 | 48 | 0.9 | NT | NT | NT | 332.5 | 37.6 | 95 | 24 | 111/77 | > 95% |
October 11, 2022 | 4.78 | 3.64 | 0.88 | 99 | 56 | 1.3 | 0.096 | NT | NT | NT | 37.3 | 131 | 20 | 128/84 | > 95% |
October 12, 2022 | 5.89 | 4.78 | 0.73 | 98 | 54 | 1.08 | NT | NT | 1.11 | NT | 37.2 | 104 | 26 | 84/59 | > 95% |
October 14, 2022 | 5.1 | 4.05 | 0.66 | 97 | 56 | 1.14 | NT | NT | NT | NT | 37.2 | 117 | 22 | 97/60 | > 95% |
October 15, 2022 | 6.06 | 4.82 | 0.77 | 99 | 63 | 0.41 | NT | NT | NT | NT | 36.3 | 105 | 20 | 90/62 | > 95% |
October 16, 2022 | 7.05 | 5.69 | 0.88 | 101 | 74 | 0.41 | NT | NT | NT | 346 | 36.5 | 120 | 23 | 97/67 | > 95% |
Testing date | Laboratory examination items | Results |
September 26, 2022 | Nucleic acid detection of 13 pathogens from nasopharyngeal swab | Human Rhino Virus and Mycoplasma Pneumoniae were positive, and others were all negative |
September 26, 2022 | T-cell spot of tuberculosis assay | Negative |
September 26, 2022 | EBV antibodies | EBVCA-IgM was 1.26 U/mL, EBVCA-IgG was 10.9 U/mL, EBNA-IgG was more than 600 U/mL, EBEA-IgG was negative, and EBEA-IgM was 0.06 COI |
September 26, 2022 | EBV-DNA | 0 copies/mL |
September 28, 2022 | Blood culture | S. typhimurium was positive |
September 30, 2022 | Widal test | FDSO, FDSH, FDSA, FDSB, and FDSC were all less than 1:40 |
October 1, 2022 | Stool culture | Negative |
October 1, 2022 | Cerebrospinal fluid culture | Negative |
October 4, 2022 | Blood culture for the second time | Negative |
October 7, 2022 | Urine culture | Negative |
October 7, 2022 | Sputum culture | Negative |
October 11, 2022 | Bone marrow culture | Negative |
October 17, 2022 | Widal test for the second time | FDSO and FDSH were both 1:40, while FDSA, FDSB, and FDSC were less than 1:40 |
- Citation: Chen YY, Xu XZ, Xu XJ. Low interleukin-10 level indicates a good prognosis in Salmonella enterica serovar typhimurium-induced pediatric hemophagocytic lymphohistiocytosis: A case report. World J Clin Cases 2024; 12(9): 1660-1668
- URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1660.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i9.1660